IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion
Completed
Phase N/A ResultsSummary of Purpose
Stroke is the third leading cause of death in the United States, responsible for 158,488 deaths in 1998 (American Heart Association). Nationwide, each year, an estimated 600,000 to 750,000 people suffer a new or recurrent stroke. Cerebral infarction comprises 80% of all strokes and is the result of a complex series of cellular metabolic events that occur rapidly after interruption of blood flow to a region of the...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 4 November 2011.
1 Mar 2004 | 14 Feb 2008 | 1 Sep 2007 | 1 Dec 2008 | 1 Nov 2011 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Open Label
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
Not available
View Trial Locations
Recruitment
- Enrollment: 7
- Gender: Both
- Minimum Age: 19 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- Souvik Sen, MD